DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Greenwich, CT
Soleus Capital is a healthcare investment firm that is primarily focused on the innovative areas of life sciences, including biotech and medtech.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Soleus Bb Spv, LLC | 2019 | Mature | $8.3M | $8.5M | 0 |
| Soleus Private Equity Fund I, L.P. | 2018 | Harvest | $85.5M | $25.3M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Bridge to Life Ltd | IL | unknown | $110M | n/a | Unknown | Aug 12, 2026 |
| Crystalys Therapeutics | n/a | Series b | $130M | n/a | Unknown | Jul 22, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | Wellington Management | 1 | 1 | Jul 22, 2026 | One time |
| Trails Edge Capital Partners | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
| Catalys Pacific | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
| Soleus Capital Management, L.P. | SR One | 1 | 1 | Jul 22, 2026 | One time |
| Soleus Capital Management, L.P. | Cormorant Asset Management | 1 | 1 | Jul 22, 2026 | One time |
| Soleus Capital Management, L.P. | Frazier Life Sciences | 1 | 1 | Jul 22, 2026 | One time |
| Soleus Capital Management, L.P. | Pivotal | 1 | 1 | Jul 22, 2026 | One time |
| Soleus Capital Management, L.P. | Lightstone Ventures | 1 | 1 | Jul 22, 2026 | One time |
| KCap Biotechnology Fund | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
| HBM Healthcare Investments | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
| Perceptive Xontogeny Venture Funds | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
| Pivotal Life Sciences | Soleus Capital Management, L.P. | 1 | 1 | Jul 22, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Harold James Schaaff (General Counsel; Chief Compliance Officer), Benjamin Andrew Lund (Limited Partner), Steven Joseph Musumeci (Chief Operating Officer; Limited Partner), GUY B Levy (Sole Owner), David Allen Canner (Limited Partner), Charles Arthur Davis (Member), Stephen Nmn Friedman (Member), Michael Anthony Coppola (Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan